{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T09:45:13Z","timestamp":1784022313932,"version":"3.55.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.pnpbp.2010.01.005","type":"journal-article","created":{"date-parts":[[2010,1,12]],"date-time":"2010-01-12T09:59:28Z","timestamp":1263290368000},"page":"387-392","source":"Crossref","is-referenced-by-count":30,"title":["MDR1 gene polymorphisms and response to acute risperidone treatment"],"prefix":"10.1016","volume":"34","author":[{"given":"Matej","family":"Kastelic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jure","family":"Kopriv\u0161ek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanka Kores","family":"Plesni\u010dar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Serretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Mandelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Locatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iztok","family":"Grabnar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vita","family":"Dol\u017ean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2010.01.005_bib1","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.jpsychires.2007.10.007","article-title":"Gene polymorphism influencing treatment response in psychotic patients in a naturalistic setting","volume":"42","author":"Alenius","year":"2008","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.pnpbp.2010.01.005_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1176\/ajp.151.12.1","article-title":"Practice guideline for the treatment of patients with bipolar disorder. American Psychiatric Association","volume":"151","author":"American Psychiatric Association","year":"1994","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.pnpbp.2010.01.005_bib3","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s002130050726","article-title":"Distribution after repeated oral administration of different dose levels of risperidone and 9-hydroxy-risperidone in the brain and other tissues of rat","volume":"139","author":"Aravagiri","year":"1998","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2010.01.005_bib4","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1192\/bjp.154.5.672","article-title":"A rating scale for drug-induced akathisia","volume":"154","author":"Barnes","year":"1989","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pnpbp.2010.01.005_bib5","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.seizure.2008.01.003","article-title":"The influence of C3435T polymorphism of ABCB1 gene on penetration of phenobarbital across the blood-brain barrier in patients with generalized epilepsy","volume":"17","author":"Basic","year":"2008","journal-title":"Seizure"},{"key":"10.1016\/j.pnpbp.2010.01.005_bib6","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.2174\/1381612043384844","article-title":"ABC transporters and the blood\u2013brain barrier","volume":"10","author":"Begley","year":"2004","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.pnpbp.2010.01.005_bib7","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s00228-008-0521-7","article-title":"Genetic determinants of methotrexate toxicity in rheumatoid arthritis patients: a study of polymorphisms affecting methotrexate transport and folate metabolism","volume":"64","author":"Bohanec Grabar","year":"2008","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.pnpbp.2010.01.005_bib8","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0024-3205(02)01680-6","article-title":"In vitro P-glycoprotein affinity for atypical and conventional antipsychotics","volume":"71","author":"Boulton","year":"2002","journal-title":"Life Sci"},{"key":"10.1016\/j.pnpbp.2010.01.005_bib9","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jpsychires.2006.10.002","article-title":"Associations between MDR1 gene polymorphisms and schizophrenia and therapeutic response to olanzapine in female schizophrenic patients","volume":"42","author":"Bozina","year":"2008","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.pnpbp.2010.01.005_bib10","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1067\/mcp.2001.114164","article-title":"Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects","volume":"69","author":"Cascorbi","year":"2001","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pnpbp.2010.01.005_bib11","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/sj.clpt.6100052","article-title":"ABCB1 pharmacogenetics: progress, pitfalls, and promise","volume":"81","author":"Chinn","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pnpbp.2010.01.005_bib12","series-title":"Statistical power analysis for the behavioral sciences","author":"Cohen","year":"1988"},{"key":"10.1016\/j.pnpbp.2010.01.005_bib13","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s00406-006-0664-4","article-title":"ABC drug transporter at the blood\u2013brain barrier: effects on drug metabolism and drug response","volume":"256","author":"Ebinger","year":"2006","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.pnpbp.2010.01.005_bib14","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1023\/A:1006938908284","article-title":"Metabolism, pharmacogenetics, and metabolic drug\u2013drug interactions of antipsychotic drugs","volume":"19","author":"Fang","year":"1999","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.pnpbp.2010.01.005_bib15","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences","volume":"39","author":"Faul","year":"2007","journal-title":"Behav Res Methods"},{"key":"10.1016\/j.pnpbp.2010.01.005_bib16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.5414\/CPP38069","article-title":"P-glycoprotein: a defense mechanism limiting oral bioavailability and CNS accumulation of drugs","volume":"38","author":"Fromm","year":"2000","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.pnpbp.2010.01.005_bib17","doi-asserted-by":"crossref","unstructured":"Guy W. ECDEU Assessment manual for psychopharmacology: revised. 76-338 DPNA, editor.; Rockville, MD. 1976.","DOI":"10.1037\/e591322011-001"},{"key":"10.1016\/j.pnpbp.2010.01.005_bib18","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/clpt.1993.146","article-title":"Pharmacokinetics of the novel antipsychotic agent risperidone and the prolactin response in healthy subjects","volume":"54","author":"Huang","year":"1993","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pnpbp.2010.01.005_bib19","doi-asserted-by":"crossref","first-page":"553","DOI":"10.2165\/00003088-200443090-00001","article-title":"The MDR1 (ABCB1) gene polymorphism and its clinical implications","volume":"43","author":"Ieiri","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.pnpbp.2010.01.005_bib20","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00004850-200503000-00002","article-title":"Prediction of response to risperidone treatment with respect to plasma concencentrations of risperidone, catecholamine metabolites, and polymorphism of cytochrome P450 2D6","volume":"20","author":"Kakihara","year":"2005","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2010.01.005_bib21","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1176\/appi.ajp.162.7.1243","article-title":"\u201cA gene for...\u201d: the nature of gene action in psychiatric disorders","volume":"162","author":"Kendler","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2010.01.005_bib22","first-page":"35","article-title":"Frequency of common MDR1 gene variants in a Polish population","volume":"58","author":"Kurzawski","year":"2006","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.pnpbp.2010.01.005_bib23","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.yebeh.2007.04.013","article-title":"Association between ABCB1 C3435T polymorphism and drug-resistant epilepsy in Han Chinese","volume":"11","author":"Kwan","year":"2007","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.pnpbp.2010.01.005_bib24","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.jpba.2009.06.013","article-title":"Simultaneous determination of risperidone and 9-hydroxyrisperidone enantiomers in human blood plasma by liquid chromatography with electrochemical detection","volume":"50","author":"Locatelli","year":"2009","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.pnpbp.2010.01.005_bib25","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1124\/jpet.102.039255","article-title":"Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs","volume":"303","author":"Mahar Doan","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2010.01.005_bib26","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","article-title":"A simple salting out procedure for extracting DNA from human nucleated cells","volume":"16","author":"Miller","year":"1988","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.pnpbp.2010.01.005_bib27","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1111\/j.1528-1167.2008.01661.x","article-title":"Association of ABCB1 genetic variants 3435C>T and 2677G>T to ABCB1 mRNA and protein expression in brain tissue from refractory epilepsy patients","volume":"49","author":"Mosyagin","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.pnpbp.2010.01.005_bib28","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3109\/10401230109147385","article-title":"Disorders associated with conventional vs. atypical antipsychotics","volume":"13","author":"Nasrallah","year":"2001","journal-title":"Ann Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2010.01.005_bib29","first-page":"99","article-title":"Interactions between the cytochrome P450 system and the second-generation antipsychotics","volume":"28","author":"Prior","year":"2003","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.pnpbp.2010.01.005_bib30","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00406-004-0556-4","article-title":"Risperidone plasma levels, clinical response and side-effects","volume":"255","author":"Riedel","year":"2005","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.pnpbp.2010.01.005_bib31","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2133\/dmpk.20.391","article-title":"MDR1 genotype-related pharmacokinetics: fact or fiction?","volume":"20","author":"Sakaeda","year":"2005","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.pnpbp.2010.01.005_bib32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(02)00169-2","article-title":"Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview","volume":"55","author":"Schinkel","year":"2003","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.pnpbp.2010.01.005_bib33","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1073\/pnas.94.8.4028","article-title":"Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins","volume":"94","author":"Schinkel","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pnpbp.2010.01.005_bib34","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s002130051171","article-title":"Cytochrome P450 2D6 genotype and steady state plasma levels of risperidone and 9-hydroxyrisperidone","volume":"147","author":"Scordo","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2010.01.005_bib35","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2174\/0929867043456043","article-title":"New antipsychotics and schizophrenia: a review on efficacy and side effects","volume":"11","author":"Serretti","year":"2004","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.pnpbp.2010.01.005_bib36","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s12017-008-8041-2","article-title":"Functional polymorphism of the human multidrug resistance gene (MDR1) and polydipsia\u2013hyponatremia in schizophrenia","volume":"10","author":"Shinkai","year":"2008","journal-title":"Neuromolecular Med"},{"key":"10.1016\/j.pnpbp.2010.01.005_bib37","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1056\/NEJMoa021986","article-title":"Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1","volume":"348","author":"Siddiqui","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pnpbp.2010.01.005_bib38","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1528-1167.2005.46304.x","article-title":"Lack of association between the C3435T polymorphism in the human multidrug resistance (MDR1) gene and response to antiepileptic drug treatment","volume":"46","author":"Sills","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.pnpbp.2010.01.005_bib39","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal side effects","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"10.1016\/j.pnpbp.2010.01.005_bib40","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s002130000576","article-title":"Relationship between plasma risperidone and 9-hydroxyrisperidone concentrations and clinical response in patients with schizophrenia","volume":"153","author":"Spina","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2010.01.005_bib41","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2174\/0929867043456070","article-title":"A critical review of atypical antipsychotic utilization: comparing monotherapy with polypharmacy and augmentation","volume":"11","author":"Stahl","year":"2004","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.pnpbp.2010.01.005_bib42","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/01.ypg.0000194441.04684.db","article-title":"Association of treatment-resistant schizophrenia with the G2677A\/T and C3435T polymorphisms in the ATP-binding cassette subfamily B member 1 gene","volume":"16","author":"Takao","year":"2006","journal-title":"Psychiatr Genet"},{"key":"10.1016\/j.pnpbp.2010.01.005_bib43","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/1520-6017(200011)89:11<1371::AID-JPS1>3.0.CO;2-D","article-title":"Transporter-mediated permeation of drugs across the blood-brain barrier","volume":"89","author":"Tamai","year":"2000","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.pnpbp.2010.01.005_bib44","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1212\/01.WNL.0000137051.33486.C7","article-title":"Failure to confirm association of a polymorphism in ABCB1 with multidrug-resistant epilepsy","volume":"63","author":"Tan","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.pnpbp.2010.01.005_bib45","series-title":"HLA: genetic diversity of HLA functional and medical implication. Proceedings of the 12th international histocompatibility workshop and conference","first-page":"307","article-title":"Anthropological features of the East European region","author":"Tiilikainen","year":"1997"},{"key":"10.1016\/j.pnpbp.2010.01.005_bib46","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/bioinformatics\/btm058","article-title":"A new JAVA interface implementation of THESIAS: testing haplotype effects in association studies","volume":"23","author":"Tregouet","year":"2007","journal-title":"Bioinformatics"},{"key":"10.1016\/j.pnpbp.2010.01.005_bib47","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1046\/j.1529-8817.2003.00085.x","article-title":"A new algorithm for haplotype-based association analysis: the stochastic-EM algorithm","volume":"68","author":"Tregouet","year":"2004","journal-title":"Ann Hum Genet"},{"key":"10.1016\/j.pnpbp.2010.01.005_bib48","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/FPC.0b013e328329940b","article-title":"Non-response to antiepileptic pharmacotherapy is associated with the ABCC2 -24C>T polymorphism in young and adult patients with epilepsy","volume":"19","author":"Ufer","year":"2009","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.pnpbp.2010.01.005_bib49","series-title":"HLA 1998","first-page":"180","article-title":"Caucasian Slovenian normal","author":"Vidan-Jeras","year":"1998"},{"key":"10.1016\/j.pnpbp.2010.01.005_bib50","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1172\/JCI8267","article-title":"Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood\u2013cerebrospinal fluid barrier","volume":"105","author":"Wijnholds","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pnpbp.2010.01.005_bib51","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.pnpbp.2005.06.019","article-title":"Association between multidrug resistance 1 (MDR1) gene polymorphisms and therapeutic response to bromperidol in schizophrenic patients: a preliminary study","volume":"30","author":"Yasui-Furukori","year":"2006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2010.01.005_bib52","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.pnpbp.2007.04.021","article-title":"Association between major multidrug resistance 1 (MDR1) gene polymorphisms and plasma concentration of prolactin during risperidone treatment in schizophrenic patients","volume":"31","author":"Yasui-Furukori","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2010.01.005_bib53","article-title":"Clinical response to risperidone in relation to plasma drug concentrations in acutely exacerbated schizophrenic patients","author":"Yasui-Furukori","year":"2009","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2010.01.005_bib54","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000054932","article-title":"Possible relationship between combined plasma concentrations of risperidone plus 9-hydroxyrisperidone and extrapyramidal symptoms","volume":"44","author":"Yoshimura","year":"2001","journal-title":"Preliminary study. Neuropsychobiology"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584610000114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584610000114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,25]],"date-time":"2019-05-25T03:00:34Z","timestamp":1558753234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584610000114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0278584610000114"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2010.01.005","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}